Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1984; 52(02): 214
DOI: 10.1055/s-0038-1661176
DOI: 10.1055/s-0038-1661176
Letter to the Editor
Monitoring Plasma Antithrombin-III Levels During Infusion of Antithrombin-III Concentrate
Further Information
Publication History
Received 07 May 1984
Accepted 15 June 1984
Publication Date:
19 July 2018 (online)
-
References
- 1 Balla G, Misz M, Karmazsin L, Rák K. Antithrombin III determination by rate (kinetic) nephelometry. Thromb Haemostas 1984; 51: 9-11
- 2 Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thrombos Diathes Haemorrh 1965; 13: 516-530
- 3 Rosenberg RD. Action and interaction of antithrombin and heparin. N Engl J Med 1975; 292: 146-151
- 4 ødegård OR, Abildgaard U. Antithrombin-III: Critical review of assay methods. Significance of variations in health and disease. Haemostasis 1978; 7: 127-134
- 5 Mosvold J, Abildgaard U, Jenssen H, Andersen R. Low antithrombin III in acute hepatic failure at term. Scand J Haematol 1982; 29: 48-50
- 6 Astrup T, Jespersen J. Thrombosis, disseminated intravascular coagulation, and the dynamic haemostatic balance. Aspects of prophylaxis and treatment. Inter Angio 1984 (in press)
- 7 Miller-Andersson M, Borg H, Andersson LO. Purification of antithrombin III by affinity chromatography. Thromb Res 1974; 5: 439-452
- 8 Brandt P. Observations during the treatment of antithrombin III deficient women with heparin and antithrombin-III concentrate during pregnancy, parturition and abortion. Thromb Res 1981; 22: 15-24
- 9 Jespersen J, Rasmussen NR, Sidelmann J. Differences between functional and immunologic determinations of plasma antithrombin during the treatment of disseminated intravascular coagulation by infusion of antithrombin-III concentrate. Acta Chir Scand 1982; (Suppl. 148) suppl 509: 105-107
- 10 Marciniak E, Gockerman JP. Kinetics of elimination of antithrombin III concentrate in heparinized patients. Br J Haematol 1981; 48: 617-625
- 11 Mannucci PM, Boyer C, Wolf M, Tripodi A, Larrieu MJ. Treatment of congenital antithrombin III deficiency with concentrates. Br J Haematol 1982; 50: 531-535
- 12 Barrowcliffe TW, Eggleton CA, Mahmoud M. Studies of the heterogeneity of antithrombin III concentrates. Br J Haematol 1983; 55: 37-46